StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.24−0.08 (-6.44%)

Close on Nov 17, 2026Market cap $5.68MP/E –Yield –

Biomerica total assets

Total assets on the balance sheet at the end of each period.

Biomerica's total assets was $8.07M at Aug 31, 2026. For fiscal 2026 it was $6.76M, up 13.7% from the year before. Over ten years it grew 1.7% a year on average. The highest annual figure on record is $17.26M in fiscal 2020.

Annual total assets

PeriodPeriod endValueChange
FY2026May 31, 2026$6.76M+13.7%
FY2025May 31, 2025$5.95M-35.8%
FY2024May 31, 2024$9.25M-36.0%
FY2023May 31, 2023$14.45M+27.1%
FY2022May 31, 2022$11.37M-3.8%
FY2021May 31, 2021$11.82M-31.5%
FY2020May 31, 2020$17.26M+229.1%
FY2019May 31, 2019$5.25M+0.4%
FY2018May 31, 2018$5.22M+4.1%
FY2017May 31, 2017$5.02M-12.4%
FY2016May 31, 2016$5.73M-6.5%
FY2015May 31, 2015$6.12M-5.3%
FY2014May 31, 2014$6.47M+1.2%
FY2013May 31, 2013$6.39M+14.8%
FY2012May 31, 2012$5.57M+12.4%
FY2011May 31, 2011$4.96M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ3 2026Aug 31, 2026$8.07M+17.8%
Q4 FY2026CQ2 2026May 31, 2026$6.76M+13.7%
Q3 FY2026CQ1 2026Feb 28, 2026$4.88M-33.9%
Q2 FY2026CQ4 2025Nov 30, 2025$6.03M-17.0%
Q1 FY2026CQ3 2025Aug 31, 2025$6.85M-12.9%
Q4 FY2025CQ2 2025May 31, 2025$5.95M-35.8%
Q3 FY2025CQ1 2025Feb 28, 2025$7.38M-28.7%
Q2 FY2025CQ4 2024Nov 30, 2024$7.27M-38.5%
Q1 FY2025CQ3 2024Aug 31, 2024$7.87M-40.5%
Q4 FY2024CQ2 2024May 31, 2024$9.25M-36.0%
Q3 FY2024CQ1 2024Feb 29, 2024$10.34M+26.0%
Q2 FY2024CQ4 2023Nov 30, 2023$11.83M+19.4%
Q1 FY2024CQ3 2023Aug 31, 2023$13.22M+19.6%
Q4 FY2023CQ2 2023May 31, 2023$14.45M+27.1%
Q3 FY2023CQ1 2023Feb 28, 2023$8.21M-53.2%
Q2 FY2023CQ4 2022Nov 30, 2022$9.91M-33.1%
Q1 FY2023CQ3 2022Aug 31, 2022$11.05M-4.0%
Q4 FY2022CQ2 2022May 31, 2022$11.37M-3.8%
Q3 FY2022CQ1 2022Feb 28, 2022$17.56M+31.6%
Q2 FY2022CQ4 2021Nov 30, 2021$14.81M+2.3%
Q1 FY2022CQ3 2021Aug 31, 2021$11.52M-27.5%
Q4 FY2021CQ2 2021May 31, 2021$11.82M-31.5%
Q3 FY2021CQ1 2021Feb 28, 2021$13.35M+62.5%
Q2 FY2021CQ4 2020Nov 30, 2020$14.48M+105.7%
Q1 FY2021CQ3 2020Aug 31, 2020$15.89M+136.4%
Q4 FY2020CQ2 2020May 31, 2020$17.26M+229.1%
Q3 FY2020CQ1 2020Feb 29, 2020$8.22M+62.1%
Q2 FY2020CQ4 2019Nov 30, 2019$7.04M+29.7%
Q1 FY2020CQ3 2019Aug 31, 2019$6.72M+37.9%
Q4 FY2019CQ2 2019May 31, 2019$5.25M+0.4%
Q3 FY2019CQ1 2019Feb 28, 2019$5.07M+6.5%
Q2 FY2019CQ4 2018Nov 30, 2018$5.43M+12.4%
Q1 FY2019CQ3 2018Aug 31, 2018$4.88M-0.8%
Q4 FY2018CQ2 2018May 31, 2018$5.22M+4.1%
Q3 FY2018CQ1 2018Feb 28, 2018$4.76M-13.1%
Q2 FY2018CQ4 2017Nov 30, 2017$4.83M-13.5%
Q1 FY2018CQ3 2017Aug 31, 2017$4.91M–
Q4 FY2017CQ2 2017May 31, 2017$5.02M–
Q3 FY2017CQ1 2017Feb 28, 2017$5.48M–
Q2 FY2017CQ4 2016Nov 30, 2016$5.59M–

More Biomerica figures

See a number that looks wrong?